Progress in Biological Research and Treatment of Pseudomyxoma Peritonei. [PDF]
Cancers (Basel)Simple Summary Pseudomyxoma peritonei (PMP) is a rare disease and has, thus, been the focus of relatively few studies in the field of digestive system research.
Li X, Liu G, Wu W.
europepmc +2 more sources
South African Journal of Radiology, 2014 Pseudomyxoma peritonei is a rare complication of mucinous tumours of appendiceal or ovarian origin. Other associations are malignancies of the colon, urachus and biliary tree.
Binit Sureka +4 more
doaj +6 more sources
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) [PDF]
World Journal of Surgical Oncology, 2008 Background Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous tumors, disseminated intra-peritoneal implants, and mucinous ascites. So far its diagnosis remains challenging to most clinicians.
Huang Che-Jen +3 more
doaj +4 more sources
Frontiers in Oncology, 2022 BackgroundPseudomyxoma peritonei is a rare disease that presents as a malignant tumor on the peritoneal surface. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is the standard treatment for this disease and frequently ...
Xiaoyun Gao +9 more
doaj +2 more sources
New insights in the management of pseudomyxoma peritonei. [PDF]
J Surg OncolAbstract While a rare entity, peritoneal pseudomyxoma treatment evolves. Decision‐making criteria improve with imaging development and exploratory laparoscopy. Surgery remains at the core of the therapeutic strategy whatever disease progression. Complete cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) is standard of care. Iterative
Pastier C, De Hingh IHJT, Goéré D.
europepmc +2 more sources
Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: Results from a structured surveillance programme. [PDF]
Colorectal DisAbstract Aim Low‐grade appendiceal mucinous neoplasm (LAMN) of the appendix is a rare tumour that can progress to pseudomyxoma peritonei (PMP). There is a lack of standardization of surveillance following resection of LAMN as the progression rate to PMP is unclear.
Hannan E +7 more
europepmc +2 more sources
A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models. [PDF]
J Surg OncolAbstract Background and Objectives Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics.
Varinelli L +13 more
europepmc +2 more sources
Appendiceal Mucocele Diagnosed in Patients with Inflammatory Bowel Disease Using Endoscopic Ultrasound [PDF]
Case Reports in Medicine, 2012 When a bulging appendiceal orifice is observed during surveillance colonoscopy, the possibility of appendiceal mucocele must be considered. Appendiceal mucocele is a rare group of lesions characterized by mucinous distension of the appendiceal lumen with
Uni Wong, Peter Darwin
doaj +3 more sources
Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei [PDF]
Annals of Thoracic Surgery Short ReportsPleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD +7 more
doaj +2 more sources
A case of Pseudomyxoma Peritonei of an unexpected origin
Diagnostic Pathology, 2021 Background Pseudomyxoma peritonei (PMP) is a complex and partially understood disease defined by mucin deposits in the peritoneal cavity, mostly of appendiceal origin caused by the rupture of a mucocele often containing Low or High grade Appendiceal ...
Marie Csanyi-Bastien +3 more
doaj +2 more sources